V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008473 | 260005672 | 1.83 | null | null | 2014-10-25 | 2014-10-28 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260027981 | RITUXIMAB |
| 260008474 | 260005672 | null | 83.6 | Curative (C) | 2017-09-13 | 2017-09-13 | PACIFICO TRIAL | 2 | N | 260027981 | CISPLATIN |
| 260008475 | 260005673 | 1.68 | null | Disease modification (D) | 2018-10-21 | 2018-10-22 | PACIFICO TRIAL | 02 | N | 260027987 | ESHAP |
| 260008476 | 260005673 | 1.74 | 71.3 | Adjuvant (A) | 2018-01-06 | 2018-01-08 | ABVD | 02 | N | 260027987 | CHOP |
| 260008477 | 260015526 | 1.83 | 63.9 | Curative (C) | 2014-04-16 | 2014-04-16 | Chlorambucil + Pred + Rituximab | 01 | N | 260027993 | PACIFICO TRIAL |
| 260008478 | 260005674 | null | 63.2 | Curative (C) | null | 2015-02-08 | Rituximab | N | N | 260027994 | NOT MATCHED |
| 260008479 | 260005674 | null | 54.8 | Palliative (P) | 2014-07-18 | 2014-09-12 | Rituximab | N | N | 260027994 | RITUXIMAB |
| 260008480 | 260005675 | null | 71.65 | Palliative (P) | 2014-06-12 | 2014-06-14 | Rituximab (Maintenance) | N | N | 260027997 | HYDROXYCARBAMIDE |
| 260008481 | 260005675 | 1.47 | null | Curative (C) | 2016-04-17 | 2016-04-17 | Rituximab (SUBCUTANEOUS Maintenance) | 2 | N | 260027997 | CHOP |
| 260008482 | 260005676 | 1.66 | 56.7 | Curative (C) | 2016-01-27 | 2016-02-14 | Rituximab (Maintenance) | N | N | 260028000 | RITUXIMAB |
| 260008483 | 260005677 | null | null | Disease modification (D) | 2014-12-11 | 2014-12-15 | GEM-P | 02 | N | 260028003 | RITUXIMAB |
| 260008484 | 260011932 | 1.63 | 92 | Adjuvant (A) | 2017-11-05 | 2017-11-19 | Rituximab | N | N | 260028009 | RITUXIMAB |
| 260008485 | 260011932 | null | null | null | 2016-04-20 | 2016-04-21 | CISPLATIN + FLUOROURACIL | 02 | null | 260028009 | CHLORAMBUCIL |
| 260008486 | 260011932 | 1.67 | 76 | Curative (C) | 2018-09-05 | 2018-09-12 | Rituximab | N | N | 260028009 | RITUXIMAB |
| 260008487 | 260018373 | 1.78 | 81.8 | Curative (C) | 2014-11-20 | 2014-11-20 | ABVD | N | N | 260028012 | CHLORAMBUCIL + RITUXIMAB |
| 260008488 | 260018373 | 1.7 | 70.6 | Adjuvant (A) | 2016-07-18 | 2016-07-22 | Rituximab (Maintenance) | Y | N | 260028012 | CARBOPLATIN + ETOPOSIDE |
| 260008489 | 260019151 | 1.76 | 84.4 | Disease modification (D) | 2014-06-19 | 2014-07-01 | Cisplatin + Radiotherapy | 2 | N | 260028016 | CISPLATIN + ETOPOSIDE |
| 260008490 | 260019151 | 1.84 | 72.3 | null | 2015-01-19 | 2015-01-30 | Rituximab | N | N | 260028016 | RITUXIMAB |
| 260008491 | 260019151 | 1.71 | null | Palliative (P) | 2017-02-06 | 2017-02-16 | CTD | N | N | 260028016 | CHLORAMBUCIL |
| 260008492 | 260019151 | 1.72 | 67.7 | Palliative (P) | 2015-03-09 | 2015-03-10 | Rituximab (INTRAVENOUS Maintenance) | 02 | N | 260028016 | CHOP |
| 260008493 | 260005678 | 1.47 | 81.8 | Disease modification (D) | 2014-02-09 | 2014-02-09 | Rituximab (Maintenance) | N | N | 260028025 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008494 | 260005678 | null | 98.6 | Adjuvant (A) | null | 2016-07-17 | Chlorambucil | null | null | 260028025 | BENDAMUSTINE |
| 260008495 | 260005679 | 1.8 | null | null | 2016-08-06 | 2016-08-06 | Rituximab | 02 | N | 260028030 | BENDAMUSTINE |
| 260008496 | 260011934 | 1.8 | 93 | Curative (C) | 2013-06-12 | 2013-06-13 | Rituximab (Maintenance) | null | Y | 260028031 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008497 | 260005680 | 1.75 | 96.4 | Curative (C) | 2018-07-24 | 2018-07-24 | Rituximab | N | N | 260028033 | BENDAMUSTINE |
| 260008498 | 260005681 | null | null | Disease modification (D) | null | 2018-12-07 | Azacitidine | N | N | 260028034 | RITUXIMAB |
| 260008499 | 260005681 | 1.73 | 90.9 | Curative (C) | null | 2014-03-06 | VINCRISTINE | 02 | N | 260028034 | BENDAMUSTINE |
| 260008500 | 260005682 | null | 69.6 | Palliative (P) | 2014-09-12 | 2014-09-14 | RCEOP | N | null | 260028038 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260008501 | 260005682 | 0 | null | Adjuvant (A) | 2014-10-11 | 2014-10-14 | CISPLATIN + ETOPOSIDE | N | N | 260028038 | TRIAL |
| 260008502 | 260005683 | null | null | Palliative (P) | null | 2014-05-23 | CYCLOPHOSPHAMIDE | N | null | 260028041 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008503 | 260005683 | 1.75 | 87.4 | Palliative (P) | 2016-11-22 | 2016-11-28 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 260028041 | TRIAL |
| 260008504 | 260005683 | 1.55 | 116.5 | null | 2017-06-19 | 2017-06-19 | Rituximab (Maintenance) | 99 | null | 260028041 | RITUXIMAB |
| 260008505 | 260005684 | 1.7 | 68.3 | Curative (C) | 2018-01-26 | 2018-01-26 | null | 2 | N | 260028044 | PEMBROLIZUMAB |
| 260008506 | 260005685 | 1.75 | null | Curative (C) | 2014-03-06 | 2014-03-21 | ABVD | N | N | 260028045 | RITUXIMAB |
| 260008507 | 260011938 | 1.71 | 63.9 | Adjuvant (A) | 2016-09-18 | 2016-10-10 | Rituximab (SUBCUTANEOUS Maintenance) | N | Y | 260028046 | CISPLATIN + RT |
| 260008508 | 260011938 | 1.88 | 104 | Disease modification (D) | 2015-02-25 | 2015-02-25 | CHLORAMBUCIL + RITUXIMAB | 02 | N | 260028046 | RITUXIMAB |
| 260008509 | 260005686 | null | 104 | Adjuvant (A) | 2018-01-10 | 2018-01-10 | Rituximab | null | null | 260028050 | HYDROXYCARBAMIDE |
| 260008510 | 260005686 | 1.61 | null | Disease modification (D) | 2015-09-20 | 2015-09-20 | CHOP - 21 days | 2 | N | 260028050 | RCEOP |
| 260008511 | 260015530 | null | 77 | Curative (C) | 2017-04-02 | 2017-04-08 | RCEOP | N | N | 260028057 | RITUXIMAB |
| 260008512 | 260005687 | 1.79 | 69.6 | Palliative (P) | 2017-06-27 | 2017-06-27 | Cyclophosphamide High Dose | N | N | 260028058 | OXALIPLATIN + MDG |
| 260008513 | 260005688 | 1.72 | 81 | Adjuvant (A) | 2014-09-06 | 2015-02-16 | Carboplatin + Pemetrexed | N | N | 260028059 | CISPLATIN + ETOPOSIDE |
| 260008514 | 260005689 | null | 0 | null | null | 2017-04-25 | CYCLOPHOSPHAMIDE | null | null | 260028061 | RITUXIMAB |
| 260008515 | 260011940 | 1.65 | 72 | Curative (C) | 2015-06-08 | 2015-06-11 | Rituximab | N | N | 260028064 | NOT MATCHED |
| 260008516 | 260011940 | 1.8 | null | Curative (C) | 2013-11-12 | 2013-11-15 | GDP | 02 | null | 260028064 | BENDAMUSTINE |
| 260008517 | 260011940 | null | 93 | Curative (C) | 2014-09-24 | 2014-09-26 | ESHAP | N | N | 260028064 | RITUXIMAB |
| 260008518 | 260005690 | null | 66.9 | null | 2017-02-13 | 2017-02-18 | Rituximab | N | N | 260028073 | CISPLATIN + RT |
| 260008519 | 260005690 | 1.65 | 92.6 | null | 2013-08-25 | 2013-09-16 | MATRIX (lymphoma) | 02 | null | 260028073 | CHLORAMBUCIL |
| 260008520 | 260005691 | 1.72 | null | Disease modification (D) | 2014-11-21 | 2015-03-07 | Hydroxycarbamide | N | N | 260028075 | RITUXIMAB |
| 260008521 | 260005691 | 1.89 | 64.7 | null | null | 2017-06-02 | Rituximab | null | null | 260028075 | RITUXIMAB |
| 260008522 | 260005692 | 1.67 | 101.3 | Disease modification (D) | 2017-09-09 | 2017-09-12 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | N | 260028078 | CHLORAMBUCIL + RITUXIMAB |